ArticleJournal of thoracic disease2025
Modified thoracostomy window as a surgical treatment for chronic pleuropulmonary infections.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: It has been reported that up to 30% of patients with empyema require surgical intervention, with procedures such as the Clagett pleural window or the Eloesser flap being the last resort. The objective of this study was to compare the postoperative outcomes of patients undergoing a conventional thoracic window versus a modified technique. Methods: We conducted a retrospective cohort study between 2012 and 2023 of patients who underwent a conventional or modified thoracic window. The modified technique involved resecting 4 cm of the costal arch, typically at the level of the 5th or 6th rib. The opening was maintained patent, with its edges protected by an Alexis retractor until the infectious process resolved. Results: We performed a total of 58 procedures between 2012 and 2023. Of these, 55% (n=32) underwent conventional thoracostomy, while 45% (n=26) were treated with the modified technique. The modified technique was associated with shorter operative times (62 Conclusions: The benefit of our modified technique was demonstrated; however, a study with a larger number of patients is required to assess its true impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.